Holdings

Deep Track Capital, LP

As of Sep 30, 2026, Deep Track Capital, LP reported 67 positions worth US$5.58B. Largest: Guardant Health, Inc., BioMarin Pharmaceutical Inc. and Immunovant, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Guardant Health, Inc.2.81MUS$500M−588KSep 30, 2026
BioMarin Pharmaceutical Inc.6.37MUS$382M+3.07MSep 30, 2026
Immunovant, Inc.9.16MUS$309M−180KSep 30, 2026
Tarsus Pharmaceuticals, Inc.3.81MUS$299M+140KSep 30, 2026
Veradermics, Incorporated1.9MUS$230M−100KSep 30, 2026
Vera Therapeutics, Inc.7MUS$226M+3MSep 30, 2026
Vaxcyte, Inc.3.51MUS$200M−787KSep 30, 2026
Ocular Therapeutix, Inc.21.9MUS$168M+2.25MSep 30, 2026
United Therapeutics Corporation300KUS$163M+176KSep 30, 2026
Structure Therapeutics, Inc.5MUS$156MnewSep 30, 2026